İpek Keleş — Endo Lab

article 2023

Does the etiology of thin endometrium impact on pregnancy rates in IVF cycles?

·doi:10.1016/j.rbmo.2023.103477

2022

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle.

Frontiers in endocrinology ·doi:10.3389/fendo.2022.837880

A suggested explanation for the pituitary-suppressive effects of progestin-primed ovarian stimulation cycles (PPOS) is pituitary luteinizing hormone (LH) depletion with progestin exposure during the follicular phase. The GnRH agonist (GnRHa…

2021

Dual Trigger Compared with Human Chorionic Gonadotropin Alone and Effects on Clinical Outcome of Intracytoplasmic Sperm Injection.

International journal of fertility & sterility ·doi:10.22074/ijfs.2021.135720.1010

BackgroundThis study compared outcomes of the standard 6000 IU human chorionic gonadotropin (hCG) trigger with a dual trigger comprised of 6000 IU hCG and 1 mg leuprolide acetate for final oocyte maturation in an intracytoplasmic sperm inje…

article 2021

P–342 Are blastulation and clinical pregnancy rates in women with endometriomas different than those without?

·doi:10.1093/humrep/deab130.341

Abstract Study question Does the presence of endometrioma during ovarian stimulation affect blastulation and clinical pregnancy rates (CPR)? Summary answer Blastulation rates were similar in women with endometrioma compared to women without…